InsidersTradesSigma
申报总数
公司
▲ 买入（4 笔）
▼ 卖出（1 笔）
内部人交易记录
首席执行官已披露买入
4
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the complete record of transactions filed by Karbe Frank, 管理人员. Insider active across 4 companies, notably Myovant Sciences Ltd.. In total, 13 reports have been recorded. Split: 4 buys · 1 sell. Total volume traded: €154k. History available since 7 July 2021. The latest transaction was filed on 7 January 2026 (Disposition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Karbe Frank
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报13 总计
7,526 股@ US$221.5050.9% 占其流量Common StockSEC:0001276700-26-000002:0
7,290 股@ US$219.60100.0% 占其流量Common StockSEC:0001610618-25-000102:0
10,500 股0Common StockSEC:0000950170-25-082458:0
57,500 股0Common StockSEC:0001610618-25-000012:0
12,500 股@ US$7.926728.7% 占其流量Common StockSEC:0000950170-24-136391:0
标准退出：2025年3月13日 (T+90)
25,000 股@ US$10.164571.3% 占其流量Common StockSEC:0000950170-24-067365:0
10,500 股0Common StockSEC:0000950170-24-064820:0
62,500 股0Common StockSEC:0000950170-23-071939:0
137,005 股@ €0.664824.0% 占其流量Common StockSEC:0000950170-23-035680:0
标准退出：2023年10月25日 (T+90)
9,000 股0Common StockSEC:0001209191-23-033007:0
242,424 股@ €0.75948.4% 占其流量Common StockSEC:0000899243-23-011189:0
标准退出：2023年7月9日 (T+90)
50,000 股@ €2.096327.6% 占其流量Common StockSEC:0000899243-22-031206:0
标准退出：2022年12月14日 (T+90)
3,232 股@ US$21.75100.0% 占其流量Common SharesSEC:0001209191-21-046171:0
13 条申报中的 13 条
About Karbe Frank
KARBE FRANK is a corporate insider associated with Phathom Pharmaceuticals, Inc., Better Therapeutics, Inc., Cidara Therapeutics, Inc. and Myovant Sciences Ltd. He has 13 filings in total, and across the sampled recent filings from 2021-07-09 to 2026-01-07, buys amount to EUR 94599 and sells to EUR 1485832, with Attribution shown as the modal transaction nature.
